Key result
Initial treatment with AngII or PDBu primes bovine adrenal glomerulosa cells for enhanced secretion via persistent diacylglycerol resulting from phospholipase D signaling.
In bovine adrenal glomerulosa cells, persistent diacylglycerol resulting from phospholipase D signaling mediates the priming response to angiotensin II.
Answers are grounded in this paper and cite their sources.
Extends mechanistic insight into adrenal priming; leaves open relevance to human aldosteronism or hypertension.
Bovine adrenal glomerulosa cells are primed by an initial treatment with angiotensin II (AngII) to respond with enhanced secretion to a second exposure to AngII or agents that increase calcium influx. We hypothesized that the mechanism of priming involves a persistent increase in diacylglycerol (DAG) generated via sustained activity of phospholipase D (PLD). In this report, we sought to define the time frame of this priming response as well as determine its mechanism using assays of aldosterone secretion, PLD activation, and radiolabeled diacylglycerol levels. We found that in primary cultures priming was observed for up to 50 min after AngII washout, suggesting that the priming window is protracted in these cultures relative to freshly isolated cells. The phorbol ester, phorbol 12,13-dibutyrate (PDBu), was used to investigate the role of sustained PLD activation in the persistent DAG and priming responses. PDBu was able to both prime glomerulosa cells to respond with enhanced secretion to AngII and elicit a persistent increase in DAG after PDBu washout. This persistent increase in DAG levels with an initial exposure to PDBu or AngII was not the result of maintained PLD activity after agent removal because PLD activation returned to basal levels by 30 min after washout. Finally, inhibition of PLD signaling during the initial AngII treatment inhibited the subsequent response to AngII or another agent that increases calcium influx. Thus, our results suggest that persistent DAG resulting from PLD signaling mediates the priming response to AngII or PDBu.
No takes yet. Share an insight, caveat, or question.
Bollag et al. (2006) studied this question. Angiotensin II (AngII) or Phorbol 12,13-dibutyrate (PDBu) was evaluated on Aldosterone secretion, PLD activation, and radiolabeled diacylglycerol levels. Initial treatment with AngII or PDBu primes bovine adrenal glomerulosa cells for enhanced secretion via persistent diacylglycerol resulting from phospholipase D signaling.
Synapse has enriched 10 related papers. Consider them for comparative context: